Participants 83 111 6
chronic hepatitis B patients
Participants 191 239 6
chronic hepatitis B patients with liver fibrosis
Participants 249 300 7
57 chronic hepatitis B patients with liver fibrosis
Participants 340 476 3
45 cases in KGQG group were treated by KGQG and routine medications; 12 cases in control group were treated by routine medications only.
Participants 940 986 6
liver fibrosis in chronic hepatitis B patients
